Bookmark and Share

Micro-Cap Stock on the Move; Entest BioMedical Inc. (ENTB)

Shares of Entest BioMedical Inc. (PINK: ENTB), a biotechnology company engaged in the development of stem cell therapy treatments for chronic obstructive pulmonary disease, are continuing to climb in early trading today.

At last check, ENTB shares were trading 15.56% higher at $0.0260 on volume of 6.25 million. The stock has gained more than 90% in the last three trading sessions.

Entest BioMedical earlier this month said in a 8K filing that it entered into an Equity Purchase Agreement with Southridge Partners II LP.

As per the terms of the Equity Purchase Agreement, Southridge will buy, at ENTB’s election, up to $10 million of ENTB’s registered common stock. ENTB can deliver a put notice to Southridge at any time.


Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

All stories in are for informational purposes only. This is NOT a stock recommendation. This story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at . About is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.